No CrossRef data available.
Published online by Cambridge University Press: 24 August 2005
This section is meant to be a mutual effort. If you find an article you think should be abstracted in this section, do not be bashful—submit it for consideration to feature editor Kenneth V. Iserson care of CQ. If you do not like the editorial comments, this will give you an opportunity to respond in the letters section. Your input is desired and anticipated.
Paasche-Orlow MK, Brancati FL. Assessment of medical school institutional review board policies regarding compensation of subjects for research-related injury. American Journal of Medicine 2005;118(2):175–80.
Although the Institute of Medicine (IOM) calls for research organizations to compensate subjects for research-related injuries, it is unclear how well research institutions inform human subject-participants of this. These researchers at the Boston University School of Medicine felt that administrators may fear that candid presentation of such policies would create financial risk. They believed that informed consent language at U.S. medical schools would be particularly complex and fall short of IOM goals, especially for projects without industry sponsorship. To study that, they surveyed medical school web sites (N = 123) for informed consent language for research-related injury. Extracting text from 113 sites (92%), they evaluated their details regarding financial liability for research-related injury. When sufficient template text was available (n = 106), the readability of liability policies was compared with that of other standardized passages using Flesch-Kincaid analysis. Although they found that coverage for medical bills is offered at 61% (23/38) of schools when there is an industry sponsor, there is coverage for only 22% (22/102) of the time when there is no industry sponsor (P < 0.001). When coverage is offered in studies with no industry sponsor, half of these policies (11/22) limit it to emergency bills. Seventy-two percent (81/113) of medical school consent forms specifically rule out the possibility of monetary compensation. As for reading levels in these sections, the mean (±SD) reading grade level of liability text in consent forms is higher than that in other template paragraphs (11.5 ± 1.4 vs. 10.6 ± 1.4; P = 0.0001). The authors conclude that few U.S. medical schools meet IOM guidelines concerning research subject compensation and that funded research at most U.S. medical schools is conducted with consent form language that is particularly complex and that fails to protect subjects from the financial burden of research-related injury.
Beskow LM, Botkin JR, Daly M, Juengst ET, Lehmann LS, Merz JF, Pentz R, Press NA, Ross LF, Sugarman J, Susswein LR, Terry SF, Austin M, Burke W. Ethical issues in identifying and recruiting participants for familial genetic research. American Journal of Medical Genetics. 2004;130A(4):424–31.
To better define the ethical and informed consent requirements for family-based research, the Cancer Genetics Network Bioethics Committee at the University of North Carolina at Chapel Hill School of Public Health assembled a multidisciplinary group to explore the scientific and ethical issues that arise in the process of family-based recruitment. Family-based research is essential to understanding the genetic and environmental etiology of human disease. The success of family-based research often depends on investigators' ability to identify, recruit, and achieve a high participation rate among eligible family members. However, recruiting family members raises ethical concerns due to the tension between protecting participants' privacy and promoting research quality, and guidelines for these activities are not well established. Using a literature review and expert opinion to develop recommendations about appropriate approaches to identifying, contacting, and recruiting family members, they concluded that there is no single correct approach. Rather, they recommended that researchers consider both the nature of the particular study and its recruitment goals. They concluded that family member recruitment should be viewed as part of the research protocol and should require appropriate informed consent of the already enrolled participants. Investigators should inform prospective participants why they are being contacted, how information about them was obtained, and what will happen to that information if they decide not to participate. The recruitment process should also be sensitive to the fact that some individuals from families at increased genetic risk will have no prior knowledge of their risk status. They suggest that these recommendations will promote further discussion about the advantages and disadvantages of various approaches to family-based recruitment, and they provide a framework for considering alternative recruitment strategies and their implications.
Berkman ND, Wynia MK, Churchill LR. Gaps, conflicts, and consensus in the ethics statements of professional associations, medical groups, and health plans. Journal of Medical Ethics 2004;30(4):395–401.
How well do the ethical codes and guidelines developed by physician organizations, group practices, and healthcare plans address professional obligations toward patients and societally important issues? Believing that each of these groups follows distinct ethical guidelines that may not address these issues, the authors systematically compared physician codes of ethics with ethics policies at physician group practices and health plans. They used the 1998–99 policies of 38 organizations—18 medical associations (associations), nine physician group practices (groups), and 12 health plans (plans)—selected using random and stratified purposive sampling. A clinician and a social scientist independently abstracted each document, using a 397-item healthcare ethics taxonomy; a reconciled abstraction form was used for analysis. This study focused on ethics policies regarding professional obligation toward patients, resource allocation, and care for the vulnerable in society. They found that, although a majority of ethical statements in all three groups mention “fiduciary obligations,” associations generally address physician–patient relations, not health plan obligations, and rarely endorse physicians' obligations of advocacy, beneficence, and nonmalfeasance. Except for occasional mentions of cost effectiveness or efficiency, ethical considerations in resource allocation rarely arise in the ethics policies of all three organizational types. Very few associations, groups, or plans specifically endorse obligations to vulnerable populations. These authors concluded that, with some important exceptions, the ethics policies of associations, groups, and plans are narrowly focused and often ignore important ethical concerns for society, such as resource allocation and care for vulnerable populations. They believe that collaborative work is needed to build integrated sets of ethical standards that address the aims and responsibilities of the major stakeholders in healthcare delivery.
Reitsma AM, Moreno JD. Ethics of innovative surgery: US surgeons' definitions, knowledge, and attitudes. Journal of the American College of Surgeons 2005;200(1):103–10.
Surgical pioneers have often used patients in their operating rooms to test their innovative ideas; some worked, others didn't. Unlike the development of drugs and medical devices, “innovative surgery” is neither clearly defined nor formally regulated by governing bodies. These authors believe that this unclear status and the subsequent questionable applicability of existing federal guidelines for human subject research pose an ethical concern. To clarify U.S. surgeons' attitudes toward innovative surgery, they solicited their definitions of, opinions toward, and attitudes about such procedures. Surgeons were also invited to self-report knowledge about current federal regulations guiding human subject research and rules for informed consent for and IRB review of clinical research. Using a 46-item questionnaire, they asked these surgeons about their definition of innovative surgery versus those for research and practice, the regulations for human subject research, the need for specific informed consent, and IRB review of surgical innovations. With 665 responses, they found that surgeons expressed a fairly prudent stance when judging hypothetical innovative scenarios. Hallmarks for experimentation and clinical research as modes of innovation were defined more clearly for the surgical situation. These authors concluded that although defining criteria exist that prompt added scrutiny and review of surgical innovations before their implementation, some forms of innovation clearly fall under the current regulations for human subject research. Other surgical innovations might not fully meet the definition, but could still require some additional oversight.
Lazcano-Ponce E, Angeles-Llerenas A, Alvarez-del Rio A, Salazar-Martinez E, Allen B, Hernandez-Avila M, Kraus A. Ethics and communication between physicians and their patients with cancer, HIV/AIDS, and rheumatoid arthritis in Mexico. Archives of Medical Research 2004;35(1):66–75.
Despite evidence that open communication concerning diagnosis of a disease substantially improves the doctor–patient relationship, physicians in developing countries often provide only partial information to their patients. These Mexican researchers from the Instituto Nacional de Salud Publica in Cuernavaca carried out a cross-sectional study with 379 physicians practicing at 11 hospitals in Mexico City and in the central Mexican state of Morelos to quantify their communication patterns with patients with cancer, HIV/AIDS, and rheumatoid arthritis. Communication patterns were defined as physician self-reported communication with patients with regard to their diagnosis, prognosis, and treatment. Using logistical, ordinal, and multivariate models for analysis, they found that the principal predictors of explicit communication with cancer patients were when the clinician highly valued patient–physician communication (odds ratio [OR] 5.5, 95% confidence interval [95% CI] 2.1–14.8) or had bioethics training (OR 1.5, 95% CI 1.0–2.3). In addition, they found a very strong association between explicit communication with HIV/AIDS patients and a physician's accepting attitude toward death (OR 34.6, 95% CI 8.5–141.0). With rheumatoid arthritis patients, they observed an association between a highly paternalistic attitude on the part of the physician (OR 6.8, 95% CI 1.9–24.1) and their level of communication. They concluded that in Mexico, physicians exercise power and authority over patients in an effort that they perceive as beneficial or preventing harm (parentalism). In most cases, Mexican physicians do not seem to recognize or respect their patients' autonomy; therefore, communication is generally partial and vague. This study reinforced the need for bioethics and communication training for Mexican, as well as for all other, physicians. This is the only way to transform the doctor–patient relationship and to establish a consensus for policies and norms for communication that benefits patients.
Veatch RM. Abandon the dead donor rule or change the definition of death? Kennedy Institute of Ethics Journal 2004;14(3):261–76.
Despite common perceptions to the contrary, our definition of death is arbitrary and can be changed by altering our laws—or customs. In the most dramatic instances, anencephalics are considered dead on delivery in some countries, allowing organ retrieval, and clinically dead people are considered to still live in some cultures. (Strange, yes? But see Iserson KV: Death to Dust: What Happens to Dead Bodies? 2nd ed., Tucson, AZ: Galen Press; 2001, for the details.) Professor Veatch has again raised the issue of whether we should reconsider our rules on death, and especially those used for organ donation. He bases his discussion on research by Siminoff and colleagues that revealed that many lay people classify legally living persons in irreversible coma or persistent vegetative state (PVS) as dead, and that additional respondents, although classifying such patients as living, would be willing to procure organs from them. This paper analyzes possible implications of these findings for public policy. A majority would procure organs from those in irreversible coma or in PVS. He suggests two strategies for legitimizing such procurement. One strategy would be to make exceptions to the dead-donor rule permitting procurement from those in PVS or at least those who are in irreversible coma while continuing to classify them as living. Another strategy would be to further amend the definition of death to classify one or both groups as deceased, thus permitting procurement without violation of the dead-donor rule. Permitting exceptions to the dead-donor rule would require substantial changes in law, such as authorizing surgeons to end the lives of patients by means of organ procurement, and would weaken societal prohibitions on killing. The paper suggests that it would be easier and less controversial to further amend the definition of death to classify those in irreversible coma and PVS as dead. Incorporation of a conscience clause to permit those whose religious or philosophical convictions support whole-brain or cardiac-based death pronouncement would avoid violating their beliefs while causing no more than minimal social problems. The paper raises the question of whether those who would support an exception to the dead-donor rule in these cases and those who would support a further amendment to the definition of death could reach agreement to adopt a public policy permitting organ procurement of those in irreversible coma or PVS when proper consent is obtained.